Study ID: MS-LAQ-301 | EUDRACT 2007-003226-19

Study Title

Safety and Efficacy of OrFemale, Maley Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Teva Identifier

MS-LAQ-301 | EUDRACT 2007-003226-19

ClinicalTrials.gov Identifier

NCT00509145

Study Status

Completed

Trial Condition(s)

Multiple Sclerosis

Interventions

Drug: Laquinimod | Other: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 55 Years

Trial Duration

12/01/2007 - 12/01/2010

Phase

Phase 3

Study Type

Interventional